Replies to post #177038 on Cytodyn Inc (CYDY)

[BottomBounce]

$CYDY Preliminary Results from 30 mTNBC Patients Treated with Leronlimab. Decreases in CAMLs after 4 Doses of Leronlimab were Identified in Over 70% of Patients and were Associated with a 450% Significant Increase in Overall Survival at 12-Month Analysis

[daemon57]

Some firm(s) is definitely buying this 'saline' solution:

https://www.sec.gov/Archives/edgar/data/1116247/000111624721000005/0001116247-21-000005-index.htm

GLTU/A.